Saved in:
Bibliographic Details
Main Authors: Leclercq, Alexandre G., Bougleux, Sébastien, Moreau, Noémie N., Desmonts, Alexis, Hérault, Romain, Corroyer-Dulmont, Aurélien
Format: Preprint
Published: 2025
Subjects:
Online Access:https://arxiv.org/abs/2510.17851
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1866915584591003648
author Leclercq, Alexandre G.
Bougleux, Sébastien
Moreau, Noémie N.
Desmonts, Alexis
Hérault, Romain
Corroyer-Dulmont, Aurélien
author_facet Leclercq, Alexandre G.
Bougleux, Sébastien
Moreau, Noémie N.
Desmonts, Alexis
Hérault, Romain
Corroyer-Dulmont, Aurélien
contents Glioblastoma (GBM) is an aggressive primary brain tumor with a median survival of approximately 15 months. In clinical practice, the Stupp protocol serves as the standard first-line treatment. However, patients exhibit highly heterogeneous therapeutic responses which required at least two months before first visual impact can be observed, typically with MRI. Early prediction treatment response is crucial for advancing personalized medicine. Disease Progression Modeling (DPM) aims to capture the trajectory of disease evolution, while Treatment Response Prediction (TRP) focuses on assessing the impact of therapeutic interventions. Whereas most TRP approaches primarly rely on timeseries data, we consider the problem of early visual TRP as a slice-to-slice translation model generating post-treatment MRI from a pre-treatment MRI, thus reflecting the tumor evolution. To address this problem we propose a Latent Diffusion Model with a concatenation-based conditioning from the pre-treatment MRI and the tumor localization, and a classifier-free guidance to enhance generation quality using survival information, in particular post-treatment tumor evolution. Our model were trained and tested on a local dataset consisting of 140 GBM patients collected at Centre François Baclesse. For each patient we collected pre and post T1-Gd MRI, tumor localization manually delineated in the pre-treatment MRI by medical experts, and survival information.
format Preprint
id arxiv_https___arxiv_org_abs_2510_17851
institution arXiv
publishDate 2025
record_format arxiv
spellingShingle Pre to Post-Treatment Glioblastoma MRI Prediction using a Latent Diffusion Model
Leclercq, Alexandre G.
Bougleux, Sébastien
Moreau, Noémie N.
Desmonts, Alexis
Hérault, Romain
Corroyer-Dulmont, Aurélien
Computer Vision and Pattern Recognition
Artificial Intelligence
Glioblastoma (GBM) is an aggressive primary brain tumor with a median survival of approximately 15 months. In clinical practice, the Stupp protocol serves as the standard first-line treatment. However, patients exhibit highly heterogeneous therapeutic responses which required at least two months before first visual impact can be observed, typically with MRI. Early prediction treatment response is crucial for advancing personalized medicine. Disease Progression Modeling (DPM) aims to capture the trajectory of disease evolution, while Treatment Response Prediction (TRP) focuses on assessing the impact of therapeutic interventions. Whereas most TRP approaches primarly rely on timeseries data, we consider the problem of early visual TRP as a slice-to-slice translation model generating post-treatment MRI from a pre-treatment MRI, thus reflecting the tumor evolution. To address this problem we propose a Latent Diffusion Model with a concatenation-based conditioning from the pre-treatment MRI and the tumor localization, and a classifier-free guidance to enhance generation quality using survival information, in particular post-treatment tumor evolution. Our model were trained and tested on a local dataset consisting of 140 GBM patients collected at Centre François Baclesse. For each patient we collected pre and post T1-Gd MRI, tumor localization manually delineated in the pre-treatment MRI by medical experts, and survival information.
title Pre to Post-Treatment Glioblastoma MRI Prediction using a Latent Diffusion Model
topic Computer Vision and Pattern Recognition
Artificial Intelligence
url https://arxiv.org/abs/2510.17851